CD19 and acute lymphoblastic leukemia: Moreover, in children and young adults with B-ALL, patients with higher cumulative fludarabine exposure during lymphodepletion had an 11-month improvement in LFS compared with patients in the lower group, and the 1-year CD19+ recurrence rate decreased from 100% to 27% [84].